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Coxiella burnetii, the etiologic agent of Q fever, is mainly responsible for endocarditis with negative blood culture results,
but only a few cases ofC. burnetii infections of aortic aneurysms have been published. We report three cases of abdominal
aortic aneurysms treated in patients with Q fever infection with simultaneous endocarditis (n  1) and previous history
of cardiac valve replacement for endocarditis (n  1). A coeliac aortic aneurysm was diagnosed in one patient treated for
acute Q fever with persistent serologic results showing chronic infection despite adequate antibiotic therapy and without
endocarditis. Resection of the aneurysm cured the chronic infection, and C. burnetii was identified by culture of the
aneurysmal wall. In the two other cases, chronic infection of C. burnetii was diagnosed by serologic examination after
surgery for an abdominal aortic aneurysm. One patient with negative blood culture results had amaurosis fugax due to
endocarditis and required aortic valve replacement; recurrent fever without evidence of valve dysfunction or infection
developed in one patient who had had prosthetic cardiac valve replacement 6 months earlier for endocarditis. Aortic
aneurysms were treated with in situ prosthetic grafts and long-term antibiotic therapy. At a mean follow-up of 12 years,
no septic aortic complications occurred, and serologic test results have remained negative. The presence of an aortic
aneurysm and cardiac valve disease seems to be a predisposing factor for chronic C. burnetii infection. Diagnosis
particularly relies on the physician’s awareness of this condition and is confirmed by serologic examination. Aortic
aneurysm resection is mandatory to cure the chronic infection and must be associated with long-term antibiotic therapy.
(J Vasc Surg 2005;42:153-8.)Coxiella burnetii is the etiologic agent of Q fever, a
zoonosis with a worldwide distribution, especially in rural
areas.1,2 Symptoms of Q fever are polymorphic and non-
specific; infection may be acute or chronic, although almost
60% of Q fever cases are asymptomatic.3-5 Endocarditis
with negative blood culture results is the most common
clinical presentation of chronic Q fever and is found in
about 60% to 70% of the cases.6-9 Other manifestations are
osteoarticular infection, chronic hepatitis, chronic pulmo-
nary infections, and isolated fever.10-12 Underlying cardio-
vascular disease, such as cardiac valve defect and aortic
aneurysm, is a risk factor for chronic Q fever infection,
although the incidence of the disease is probably underes-
timated.12-14
Because the clinical manifestations of C. burnetii vas-
cular infection are nonspecific, the diagnosis may be recog-
nized only when serologic tests are performed systemati-
cally in patients with arterial aneurysms, vascular grafts, and
endocarditis who live in an endemic area and who present
with unexplained fever and negative blood culture re-
sults.15-24 C.burnetii can also be isolated by culture25 and
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doi:10.1016/j.jvs.2005.03.022specific polymerase chain reaction (PCR) amplification
from blood and aortic aneurysm specimens.15-21, 26-30
We report three cases of aortic aneurysms operated on
in patients with Q fever and with simultaneous endocarditis
in one patient and a prior history of cardiac valve replace-
ment for endocarditis in another.
CASE REPORTS
Case 1. This case has previously been reported.18 A 65-year-
old woman, who was a heavy smoker, presented in February 1988
with general physical deterioration, weight loss, fever, and abdom-
inal pain due to granulomatous hepatitis diagnosed by a biopsy
specimen. An abdominal computed tomography (CT) scan
showed a 40-mm saccular coeliac aortic aneurysm (Fig 1). Cardiac
echography showed no evidence of endocarditis.
Serologic tests revealed acute C. burnetii infection (Fig 2).
The patient was started on doxycycline for 3 weeks, and presented
1 month after the discontinuation of antibiotics with recurrent
fever. Given the recurrent infection, rifampin was given with
doxycycline until November 1988. Serologic tests showed the
persistence of phase II antibodies (immunoglobulin G [IgG],
1,600) and the appearance of phase I antibodies (IgG, 400).
Diagnosis of chronic Q fever was confirmed, and the patient
continued to receive antibiotic therapy until September 1989
because of the persistence of fever and the increment of phase I IgG
antibodies 1,600.
In May 1990, a new episode of fever in the absence of
endocarditis led to resection of her aortic aneurysm (Fig 3), with
placement of a prosthetic graft. C. burnetii was isolated by culture
from blood, the aneurysmal aortic wall, and the thrombus at the
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Antibiotic therapy with doxycycline and rifampin was main-
tained for 3 years and then stopped when her phase I IgG antibody
titer normalized. After a 15-year follow-up, the patient has had no
recurrence of fever. Phase I IgG antibodies have been stable
(200). A CT scan showed moderate and stable dilatation of the
aortic graft (Fig 4) and of the abdominal aorta (Fig 5) of 40 mm
in diameter.
Case 2. A 47-year-old man presented in February 1992 with
an episode of subacute ischemia of the right lower limb as a
consequence of popliteal artery aneurysm thrombosis. A vascular
evaluation showed a 35-mm saccular aneurysm of the abdominal
aorta extending to the iliac arteries. The patient had a cardiac
murmur. He presented with an episode of sweating after having
spent time in the mountains with pets.
His aortic aneurysm was treated by resection and placement of
an aortobiiliac graft. On postoperative day 2, the patient had two
episodes of amaurosis fugax. The results of a carotid duplex scan
were normal. Cardiac echography showed endocarditis of the
aortic valve with presence of vegetations. Transesophageal echog-
raphy confirmed the presence of vegetations and showed a periaor-
tic abscess. Blood culture test results remained negative, and a
serologic examination showed phase I IgG antibodies 1,600,
allowing a diagnosis of chronic Q fever. Surgery of the aortic valve
was undertaken with a prosthetic St. Jude valve (St Jude Medical,
St. Paul, Minn). No organisms grew on the aortic valve, although
a specific culture for C. burnetii was not done.
Antibiotic therapy with doxycycline-rifampin was started for 6
months and then switched to doxycycline-ofloxacin for 4 years.
With a follow-up of 13 years, serologic test results have remained
negative, with phase I IgG antibodies 200. No complications
from the cardiac valve or the aortic graft have occurred.
Case 3. A 55-year-old man underwent resection of an ab-
dominal aortic aneurysm extending to the iliac arteries with place-
ment of an aortobiiliac bifurcated prosthetic graft in October
1992. An inflammatory reaction was noted on the right iliac
Fig 1. Computed tomography scan of the patient in case 1shows
a saccular coeliac aortic aneurysm.aneurysm involving the ureter. The patient’s history was relevantfor aortic valve replacement with aortocoronary bypass 6 months
earlier.
In the postoperative period from cardiac surgery, an episode of
fever of unknown origin developed. Results of blood cultures
remained negative, and fever resolved after 3 weeks of antibiotics.
During the postoperative period from the aortic surgery, a new
episode of fever occurred. Results of blood cultures were negative.
Given the patient’s previous history of aortic valve replace-
ment and the presence of an aortic aneurysm, a C. burnetii infec-
tion was suspected and confirmed by serologic tests that showed
chronic infection with a high titer of phase I antibodies (1,280).
Ciprofloxacin was started for 1 year and then switched to doxycy-
cline for 6 months because of tendinitis. A later follow-up exami-
nation revealed moderate dilatation of the aortic graft that
prompted renewal of ciprofloxacin for 18 months. The graft has
remained stable after 12 years of follow-up, without evidence of
infection. Serologic test results for C. burnetii have remained
negative, with phase I IgG antibodies 200.
DISCUSSION
Infection of an aortic aneurysm or vascular graft is an
uncommon complication. The more commonly involved
organisms are staphylococcus and salmonella, which can be
easily identified by culture.31,32 However, about 25% of
infected aneurysms and 5% to 8% of graft infections remain
without bacterial identification.33,34 This can be because of
widespread use of antibiotics before specimens are tested or
the presence of intracellular pathogens, such as C. burnetii,
that are difficult to grow in culture. Diagnosis can be
achieved by serologic examination or PCR amplification.3,4
C. burnetii is the etiologic agent of Q fever, a zoonosis
with a worldwide distribution in rural and, recently, in
urban areas.3,4 Q fever is endemic and has been described in
almost every country except New Zealand. The reservoir is
large and includes many wild and domestic animals.1-4 The
aerosol route by inhalation is the primary mode of human
contamination by C. burnetii,2 which may occur directly
from infected animals. The organism may also be spread by
the wind,2 and Q fever may occur in patients who live in
urban areas without any evident contact with animals.
Infection in humans is usually asymptomatic or mani-
fests as a mild disease such as fever, weight loss, and
abdominal pain, with spontaneous recovery. Because the
clinical presentation of Q fever is polymorphic and nonspe-
cific, the incidence of Q fever among humans is probably
underestimated. Diagnosis particularly relies upon physi-
cian’s interest and awareness of the symptoms of Q fever as
well as access to reliable diagnostic laboratories. However,
when evoked, a definitive diagnosis of the disease is easy
and is confirmed from serologic examination, with phase II
and phase I antibodies distinguishing acute from chronic
disease.
It is nowwell established that development of the chronic
infection is more often due to predisposing host factors than
the virulence of the bacterium. Patients at risk from chronicQ
fever include those with previous cardiac valve defects and, to
a lesser extent, those with aneurysms or vascular grafts as well
as immunocompromised patients.12-14,15-21
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most frequent clinical presentation of chronic Q fever,
accounting for 60% to 70% of the cases.6,8 Embolic mani-
festations that involve the brain and upper and lower limbs
are mainly due to endocarditis and are observed in 20% of
patients.10-11,15,19 The incidence of endocarditis due to C.
burnetii infection is 5% in France and 3% in the United
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Fig 2. Serologic profile of patient in case 1. Phase II
respectively. *Recurrent fever after antibiotics discontinu
aneurysm resection with 3 years antibiotic therapy. IgG,
Fig 3. An intraoperative view of coeliac aortic aneurysm in the
case 1 patient.States.4Cardiovascular disease may favor passage from acute to
chronic Q fever despite adequate antibiotic therapy. This is
due to the affinity of C. burnetii for cardiovascular tissues
and its ability, as an obligate intracellular microorganism, to
survive after gaining entry into that monocytes and macro-
phages that are present in the aortic thrombus and in
damaged cardiac valves.35 This situation has been observed
in our experience and gives pathophysiologic support to the
fact that host conditions—and above all, endocarditis and
aortic aneurysms—are the predisposing conditions for the
development of chronic Q fever despite adequate antibiotic
therapy.4,18,20 In fact, the patient of case 1 presented with
an infection relapse after antibiotic discontinuation, and her
titer of phase I IgG antibodies decreased only after the
aortic aneurysm was resected (Fig 2).
Recent studies have suggested that surgery is manda-
tory for abdominal aortic aneurysms50 mm in diameter,
but indications are not well defined in the setting of C.
burneti.36,37 Because an aortic aneurysm represents a risk
factor for the development of chronic C. burnetii disease,
we believe that with the currently available antibiotic regi-
men, surgery should be undertaken for aortic aneurysms
50 mm in patients with or without endocarditis if fevers
continue and if the results of serologic examinations remain
elevated despite adequate antibiotic treatment.
In case 1, fever discontinued and the phase I IgG
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ationaortic aneurysm, with the patient being considered cured
JOURNAL OF VASCULAR SURGERY
July 2005156 Sessa et alafter 15 years (Fig 2). Despite dilatation of the aortic graft
(Fig 4) and a 40-mm abdominal aortic aneurysm (Fig 5),
serologic results have remained negative, with no signs of
recurrent or persistent infection.
The association of an abdominal aortic aneurysm with
proven (case 2) or suspected endocarditis (case 3) has not
been previously published in the literature. In our series, it is
likely that case 2 was a noninfected aneurysm with simulta-
neous, undiagnosed C. burnetii endocarditis, whereas case 3
Fig 4. A computed tomography scan taken at the 15-y
tation.
Fig 5. A computed tomography scan taken at the 15-ye
aneurysm.was a noninfected aneurysm with prior endocarditis that wasundertreated and not diagnosed as C. burnetii infection. In
fact, there was no intraoperative evidence of aortic aneurysm
infection, although case 3 had slight periaortic inflammation.
It is probable that aortic aneurysm and endocarditis are a
unified expression of C. burnetii infection in that they repre-
sent a cardiovascular predisposing condition for development
of chronic infection.
The 13 cases ofC. burnetii infection reported literature
involve nine aneurysms (infrarenal aorta, 6; ascending
llow-up of the patient in case 1 shows aortic graft dila-
ow-up of the patient in case 1 shows an abdominal aorticear foar follaorta, 1; thoracic aorta, 1; and suprarenal aorta, 1) and four
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graft, 1; and subclavian-to-subclavian bypass, 1).15-21 The
clinical manifestations at diagnosis were a fever of38°C in
7 patients, weight loss in 6, lumbar or abdominal pain (or
both) in 4, embolic phenomena in 2, symptoms of hepatitis
in 1, and myalgia, nausea, and vomiting in 1.
The diagnosis of Q fever is generally established by
serologic tests22-24 and, more recently, by DNA amplifica-
tion using PCR-based techniques.26-30 Isolation of C. bur-
netii by culture is done only in very few laboratories because
of the risk of transmission to laboratory personnel and the
lack of sensitivity of the technique, particularly when anti-
biotics have been previously administered. In all the cases
reported in the literature, including our three cases, the
diagnosis was achieved by serologic tests, and C. burnetii
was isolated by culture in 10 cases. PCR amplification was
made in 10 cases and was positive in 7 cases.
Serologic testing allows differentiation between acute
and chronic Q infection from the antibodies profile (Fig
2).22,23 Acute Q fever is characterized by antiphase II
antibodies, whereas antiphase I antibodies are seen in the
chronic phase. A single serologic examination enables the
diagnosis of chronic Q fever. Nevertheless, the different
serologic techniques are not well standardized, and the
results are difficult to compare between the different labo-
ratories.
The National Reference Center and World Health
Organization Collaborative Center for Rickettsial Diseases
in Marseille has established the threshold of sensitivity for
the antibodies titer of C. burnetii infection.23,24 An IgG
anti-phase II titer of200 and an IgM antiphase II titer of
50 are diagnostic of recent infection. In chronic Q fever,
IgA antiphase I titers are 100 and IgG antiphase I titers
are 800.
More recently, C. burnetiiDNA amplification from clin-
ical specimens by PCR has been used successfully.29 With this
method, C. burnetii DNA can be detected retrospectively in
frozen samples and even in paraffin-embedded tissues. 29,30
An undiagnosed or untreated C. burnetii infection of
an aortic aneurysm or a vascular graft can lead to severe
complications. Of the 13 patients reported in the literature,
four (31%) died, and postoperative septic complications
developed in seven (54%).15-21 Five (38%) septic pseudo-
aneurysms of the vascular prosthesis occurred and were
adjacent to a vertebral osteomyelitis in three patients and to
an aortoduodenal fistula in two patients. Infectious com-
plications occurred in three patients before the diagnosis of
Q fever was made. In two patients, these complications
developed despite an adequate antibiotics treatment for 2
months. Two patients with complications recovered after a
reoperation, received antibiotics for a mean duration of 3
years, and are now considered cured. Of the five patients
without postoperative complications, two are considered
cured after 3 years of treatment, as shown by a normaliza-
tion of their serologic titers. Three patients are still receiv-
ing antibiotics.
In our experience, the patient in case 3 was found to have
a slight dilatation of the aortic graft at the 2-year follow-upthat was still stable 12 years later. At 15 years after surgery, the
patient in case 1 alsohadmoderate dilatationof the aortic graft
(Fig 4), with a 40-mm-diameter enlargement of the abdom-
inal aorta (Fig 5). CT scans of both patients did not show
evidence of recurrent infection, and normal titers of phase I
IgA antibodies suggested the chronic infection was cured
despite the aortic aneurysm.
Surgical treatment of the aneurysm and slight dilatation
of the aortic graft must be associated with antibiotic ther-
apy, although its optimum duration cannot be determined,
because no definite criteria for a C. burnetii cure are cur-
rently available. Suggestions have ranged from 1 year of
antibiotic therapy4,38,39 to indefinite administration.40 The
current recommendation for the treatment of Q fever en-
docarditis is at least 3 years of double coverage with doxy-
cycline-ofloxacin or doxycycline-rifampin. This same anti-
biotic protocol has been extrapolated and recommended
for the treatment of vascular infection for a minimum of 18
to 36 months.41 More recently, the combination of doxy-
cycline with chloroquine has been proposed for 18 months
in the treatment of Q fever endocarditis, although it has not
yet been evaluated in the treatment of vascular infection.
In the literature, C. burnetii vascular infections in pa-
tients without endocarditis have been treated with mono-
therapy in five cases, with doxycycline-ofloxacin in three
cases, and with doxycycline-rifampin in two cases. Five
patients received antibiotic therapy for a mean duration of 3
years and were considered cured as assessed by a normal
clinical examination and a decline in serologic titers of IgG
phase I antibodies; four patients were still receiving antibi-
otic therapy.20 In our experience, the duration of the
antibiotics regime was 3 years in the patient in case 1 and 4
years in the other two patients who underwent surgery for
infrarenal aortic aneurysms and who presented with simul-
taneous proven (case 2) or suspected (case 3) C. burnetii
endocarditis.
Duration of antibiotic therapy should be determined
from clinical, biologic, and serologic monitoring of phase I
antibody titers. Raoult et al6,41,42 proposed a decrease of
phase I IgG and IgA antibody titers to 200 as the main
predictive criterion of clinical cure. High antibody phase 1
titers to C. burnetii suggest a high risk of infection relapse
or the development of vascular complications. This situa-
tion warrants close follow-up and long-term or lifelong
antibiotic treatment. However, serologic evaluation is rec-
ommended monthly for the first 6 months after antibiotics
are discontinued and every 3 months for 2 years before
considering the patient cured.3,4,6
In conclusion, underlying cardiovascular disease, such
as a valve defect and an aortic aneurysm, is a predisposing
factor to chronic infection with C. burnetii. Diagnosis
particularly relies on the physician’s awareness of such
infection and specialized diagnostic laboratories. Q fever
should be suspected and serologic tests systematically per-
formed in patients with endocarditis and negative blood
cultures, in febrile patients with an aortic aneurysm, arte-
rial, or cardiac prosthesis, and in those with prolonged or
unexplained fever, abdominal pain, or weight loss who live
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identified by culture or by PCR of cardiac valve or aortic
tissue samples. Surgical treatment must be associated with
long-term antibiotic therapy, the duration of which should
be based on titers of phase I IgG antibodies.
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